Skip to content
1 min read

BC Platforms named Advanced drug development technology of the year in Europe 2026

Published
Share
In the spotlight

BC Platforms has been recognized by Pharma Tech Outlook Europe as “Advanced Drug Development Technology of the Year in Europe 2026”, and has also been named among the “Top Drug Discovery and Development Solutions in Europe.”

The recognition highlights BC Platforms’ leadership in evidence generation, federated data access, and AI-enabled drug development. 

Read the Pharma Tech Outlook Europe profile.Download

Read the full profile here.

Last updated

Continue reading

4 min read

BC Platforms partners with Flower Labs to enable federated machine learning across trusted research environments

Federated learning with the Flower Framework is available within BC Platforms’ trusted research environments.

Read more
3 min read

BC Platforms signs Strategic Collaboration Agreement with AWS to accelerate healthcare and life sciences innovation

BC Platforms signs a Strategic Collaboration Agreement with AWS to scale secure, AI-powered research environments.

Read more
3 min read

BC Platforms recognized by Swiss Economic Forum’s High Growth Program

BC Platforms earns the SEF.Growth High‑Potential label for secure, scalable innovation in health data.

Read more